Table 3.
Patient-reported outcomes of the two study groups at baseline and at 1-year followup
| Score | Nonoperative group | Operative group | p value | |||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Followup | Baseline | Followup | Nonoperative baseline versus followup | Operative baseline versus followup | Groups at baseline | Groups at followup | |
| WOMAC (0–240) | 49 ± 46 (1–161) |
44 ± 49 (0–164) |
59 ± 40 (5–108) |
31 ± 40 (0–153) |
0.906 | 0.001 | 0.385 | 0.499 |
| HOOS (0–100) | 67 ± 16 (43–96) |
68 ± 20 (24–95) |
62 ± 16 (38–86) |
74 ± 19 (30–100) |
0.828 | 0.004 | 0.406 | 0.329 |
| mHHS (0–91) | 61 ± 20 (13–91) |
72 ± 16 (38–91) |
57 ± 17 (38–88) |
71 ± 15 (35–91) |
0.013 | 0.001 | 0.562 | 0.952 |
Values are mean ± SD with ranges in parentheses; WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index; HOOS = Hip disability and Osteoarthritis Outcome Score; mHHS = modified Harris hip score.